Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure–function studies of lysosomal β-galactosidase and the non-lysosomal β-galactosidase-like protein-Reference-Cited by-同舟云学术

Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure–function studies of lysosomal β-galactosidase and the non-lysosomal β-galactosidase-like protein

Published:1999-10 Issue:2-3 Volume:1455 Page:85-103
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Callahan John W

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference113 articles.

1. Atypical adult GM1 gangliosidosis: Biochemical comparison with other forms of primary -galactosidase deficiency

2. Purification and characterization of human liver β-galactosidase from a patient with the adult form of GM1 gangliosidosis and a normal control

3. Tay-Sachs' disease with visceral involvement and its relationship to Niemann-Pick's disease

4. Familial Neurovisceral Lipidosis

5. Generalized Gangliosidosis

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of 6-C-alkyl-DMDP type nanomolar inhibitors of β-galactosidase and β-glucosidase based on broussonetine S and related derivatives;European Journal of Medicinal Chemistry;2024-09

2. Unraveling the diagnostic enigma: laboratory diagnosis of sphingolipid activator protein deficiencies;Journal of Laboratory and Precision Medicine;2024-07

3. A clinical case of ischemic stroke in a young patient with a previously undescribed nucleotide sequence c.808T > C (p.Tyr270His of the GLBI gene (NM_ 000404.3, GMI-gangliosidosis type 2) in a heterozygous state;Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH);2023-04-12

4. Nanomolar β-glucosidase and β-galactosidase inhibition by enantiomeric α-1-C-alkyl-1,4-dideoxy-1,4-imino-arabinitol derivatives;European Journal of Medicinal Chemistry;2023-02

5. Processed pseudogene insertion in GLB1 causes Morquio B disease by altering intronic splicing regulatory landscape;npj Genomic Medicine;2022-07-26